X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (7) 7
humans (7) 7
male (7) 7
middle aged (7) 7
adult (5) 5
cohort studies (5) 5
index medicus (5) 5
abridged index medicus (4) 4
aged (4) 4
antineoplastic agents - therapeutic use (4) 4
article (4) 4
care and treatment (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
survival (4) 4
antineoplastic agents - administration & dosage (3) 3
asthma (3) 3
chemotherapy (3) 3
non-hodgkins-lymphoma (3) 3
oncology (3) 3
prospective studies (3) 3
rituximab (3) 3
treatment outcome (3) 3
aged, 80 and over (2) 2
allergy and immunology (2) 2
analysis (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - pharmacology (2) 2
b-cell lymphoma (2) 2
body mass index (2) 2
cancer (2) 2
diagnosis (2) 2
elderly-patients (2) 2
follow-up studies (2) 2
hematology (2) 2
lymphoma, large b-cell, diffuse - complications (2) 2
lymphomas (2) 2
prognosis (2) 2
rituximab - administration & dosage (2) 2
rituximab - pharmacology (2) 2
rituximab - therapeutic use (2) 2
transplantation (2) 2
usage (2) 2
adults (1) 1
airway hyperresponsiveness (1) 1
airway management (1) 1
allergies (1) 1
and prednisone (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
asthma - drug therapy (1) 1
asthma - immunology (1) 1
asthma - physiopathology (1) 1
autografts (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
brentuximab vedotin sgn-35 (1) 1
bronchial hyperreactivity - drug therapy (1) 1
bronchial provocation tests (1) 1
cell count (1) 1
cell transformation, neoplastic - drug effects (1) 1
cell transformation, neoplastic - pathology (1) 1
chemoradiotherapy (1) 1
chemotherapy plus rituximab (1) 1
chop (1) 1
classification (1) 1
classification project (1) 1
clinical trials and observations (1) 1
consolidation (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
databases (1) 1
diagnosis, differential (1) 1
diffuse large b-cell lymphoma (1) 1
diffuse large b‐cell lymphoma (1) 1
disease (1) 1
disease-free survival (1) 1
double-blind method (1) 1
doxorubicin (1) 1
doxorubicin - administration & dosage (1) 1
drug dosages (1) 1
early stage (1) 1
enteropathy-associated t-cell lymphoma - pathology (1) 1
expression (1) 1
fdg-pet (1) 1
flow cytometry (1) 1
forced expiratory volume - drug effects (1) 1
gene-expression (1) 1
glucocorticoids (1) 1
grade follicular lymphoma (1) 1
health aspects (1) 1
hemic and lymphatic diseases (1) 1
high-dose chemotherapy (1) 1
high-dose therapy (1) 1
histamine (1) 1
histological transformation (1) 1
imatinib (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 20, pp. 1911 - 1920
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2013, Volume 163, Issue 4, pp. 487 - 495
Summary Histological transformation (HT) is a major cause of morbidity and mortality in patients with indolent non‐Hodgkin lymphoma (NHL). The multicentre... 
rituximab era | non‐Hodgkin lymphoma | diffuse large B‐cell lymphoma | stem‐cell transplantation | histological transformation | Non-Hodgkin lymphoma | Rituximab era | Histological transformation | Diffuse large B-cell lymphoma | Stem-cell transplantation | LONG-TERM SURVIVAL | stem-cell transplantation | non-Hodgkin lymphoma | diffuse large B-cell lymphoma | TRANSPLANTATION | SUPPORT | B-CELL LYMPHOMA | GRADE FOLLICULAR LYMPHOMA | REMISSIONS | HIGH-DOSE THERAPY | GENE-EXPRESSION | HEMATOLOGY | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Lymphoma, Non-Hodgkin - surgery | Antineoplastic Agents - administration & dosage | Lymphoma, Non-Hodgkin - pathology | Stem Cell Transplantation | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Rituximab | Treatment Outcome | Disease-Free Survival | Lymphoma, Non-Hodgkin - therapy | Survival Analysis | Aged | Cell Transformation, Neoplastic - drug effects | Cell Transformation, Neoplastic - pathology | Antibodies, Monoclonal, Murine-Derived - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Cohort Studies | Antimitotic agents | Chemotherapy | Databases | Analysis | Lymphomas | Antineoplastic agents | Cancer | Autografts
Journal Article
Cancer, ISSN 0008-543X, 04/2015, Volume 121, Issue 7, pp. 1032 - 1039
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB11 - AB11
Post-hoc analysis of segmental airways in patients who had airflow obstruction at baseline (FEV1% <80% predicted) treated with imatinib compared to placebo... 
Respiratory tract | Imatinib | Asthma
Journal Article
Cancer, ISSN 0008-543X, 07/2014, Volume 120, Issue 13, pp. 1993 - 1999
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB169 - AB169
  Methods We conducted a randomized, double-blind, placebo-controlled, multi-center 24 week proof-of-principle trial of imatinib in severe asthmatics with... 
Allergy and Immunology | Antimitotic agents | Care and treatment | Antineoplastic agents | Asthma | Histamine | Smooth muscle | Airway management | Allergies
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 2669 - 2669
Abstract Abstract 2669 Background The prognosis of histologic transformation (HT) of indolent non-Hodgkin's Lymphoma (NHL) in the pre-rituximab era has been... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 1610 - 1610
Abstract Abstract 1610 Background: T-cell lymphomas (TCL) are an uncommon group of diseases recently updated in the WHO classification. Accurate diagnosis... 
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 10/2016, Volume 14, Issue 10, pp. 1274 - 1281
Background: The impact of patient body habitus and sex on outcomes in diffuse large B-cell lymphoma (DLBCL) remains controversial. We investigated the impact... 
SURVIVAL | TRIAL | B-CELL LYMPHOMA | ONCOLOGY | NON-HODGKIN-LYMPHOMA | OUTCOMES | WEIGHT
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 2656 - 2656
Abstract Abstract 2656 Introduction: The International Prognostic Index (IPI) was first developed in 1993 to risk stratify patients with aggressive... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.